近岸蛋白跌3.52% 2022年上市募18.6亿

Core Viewpoint - Nearshore Protein (688137.SH) is currently trading at 40.62 yuan, reflecting a decline of 3.52% and is in a state of breaking its initial public offering price [1] Group 1: Company Overview - Nearshore Protein was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 29, 2022, with an initial offering price of 106.19 yuan per share [1] - The company issued a total of 17,543,860 shares during its IPO, with Minsheng Securities Co., Ltd. acting as the lead underwriter [1] Group 2: Fundraising and Financials - The total amount raised from the IPO was 1,862.9825 million yuan, with a net amount of 1,742.1958 million yuan after deducting issuance costs [1] - The net fundraising amount exceeded the original plan by 242.1958 million yuan [1] - The company initially aimed to raise 1,500 million yuan, which was intended for projects related to core diagnostic materials, innovative diagnostic reagent industrialization, R&D center construction, and working capital supplementation [1] Group 3: Issuance Costs - The total issuance costs for the IPO amounted to 120.7867 million yuan, with Minsheng Securities receiving underwriting and sponsorship fees of 98.4217 million yuan [1]